Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 84 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014The efficacy of adjunctive N-acetylcysteine in major depressive disorder : a double-blind, randomized, placebo-controlled trialBerk, M.; Dean, O.; Cotton, S.; Jeavons, S.; Tanious, M.; Kohlmann, K.; Hewitt, K.; Moss, K.; Allwang, C.; Schapkaitz, I.; Robbins, J.; Cobb, H.; Ng, F.; Dodd, S.; Bush, A.; Malhi, G.
2014Physical inactivity and incidence of obesity among South Australian adultsMontgomerie, A.; Chittleborough, C.; Taylor, A.; Tang, J.W.
2014Individual characteristics associated with physical activity intervention delivery mode preferences among adultsShort, C.; Vandelanotte, C.; Duncan, M.
2014A 16-year prospective study of community-onset bacteremic Acinetobacter pneumoniaDavis, J.; McMillan, M.; Swaminathan, A.; Kelly, J.; Piera, K.; Baird, R.; Currie, B.; Anstey, N.
2014Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsYeung, D.; Mauro, M.
2014LgG4 immunostaining and its implications in orbital inflammatory diseaseWong, A.; Planck, S.; Choi, D.; Harrington, C.; Troxell, M.; Houghton, D.; Stauffer, P.; Wilson, D.; Grossniklaus, H.; Dailey, R.; Ng, J.; Steele, E.; Harris, G.; Czyz, C.; Foster, J.; White, V.; Dolman, P.; Kazim, M.; Patel, P.; Edward, D.; et al.; Wallace, G.
2014IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylationSmith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
2014Haptoglobin duplicon, hemoglobin, and vitamin C: analyses in the British Women's Heart and Health Study and Caerphilly Prospective StudyGuthrie, P.; Abdollahi, M.; Gaunt, T.; Lawlor, D.; Ben-Shlomo, Y.; Gallacher, J.; Smith, G.; Day, I.; Rodriguez, S.
2014Is interpregnancy interval associated with cardiovascular risk factors in later life? A cohort studyKnipe, D.; Fraser, A.; Lawlor, D.; Howe, L.
2014Added value of soluble tumor necrosis factor-alpha receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetesForsblom, C.; Moran, J.; Harjutsalo, V.; Loughman, T.; Waden, J.; Tolonen, N.; Thorn, L.; Saraheimo, M.; Gordin, D.; Groop, P.; Thomas, M.